Marlar Riley, Abbas Fuad, Obeid Rommy, Frisbie Sean, Ghazoul Adam, Rezaee Ava, Sims Jack, Rampazzo Antonio, Bassiri Gharb Bahar
Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
Artif Organs. 2025 Jan;49(1):7-20. doi: 10.1111/aor.14841. Epub 2024 Aug 19.
Ex vivo machine perfusion (EVMP) has been established to extend viability of donor organs. However, EVMP protocols are inconsistent. We hypothesize that there is a significant relationship between specific parameters during EVMP and perfusion outcomes.
A meta-analysis of literature was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Statement. The search encompassed articles published before July 25, 2023. PubMed, Embase, and CENTRAL databases were screened using search terms "ex-vivo," "ex-situ," "machine," and "perfusion." Weight gain, an indicator of organ viability, was chosen to compare outcomes. Extracted variables included perfused organ, warm and cold ischemia time before perfusion, perfusion duration, perfusate flow, pressure, temperature, perfusate composition (presence of cellular or acellular oxygen carrier, colloids, and other supplements) and percent weight change. Data were analyzed using SPSS statistical software.
Overall, 44 articles were included. Red blood cell-based perfusates resulted in significantly lower weight gain compared to acellular perfusates without oxygen carriers (11.3% vs. 27.0%, p < 0.001). Hemoglobin-based oxygen carriers resulted in significantly lower weight gain compared to acellular perfusates (16.5% vs. 27%, p = 0.006). Normothermic perfusion led to the least weight gain (14.6%), significantly different from hypothermic (24.3%) and subnormothermic (25.0%) conditions (p < 0.001), with no significant difference between hypothermic and subnormothermic groups (24.3% vs. 25.0%, p = 0.952). There was a positive correlation between flow rate and weight gain (ß = 13.1, R = 0.390, p < 0.001).
Oxygen carriers, low flow rates, and normothermic perfusate temperature appear to improve outcomes in EVMP. These findings offer opportunities for improving organ transplantation outcomes.
体外机器灌注(EVMP)已被确立用于延长供体器官的存活期。然而,EVMP方案并不一致。我们假设EVMP期间的特定参数与灌注结果之间存在显著关系。
根据系统评价和Meta分析的首选报告项目(PRISMA)声明进行文献的Meta分析。检索范围包括2023年7月25日之前发表的文章。使用“体外”“异位”“机器”和“灌注”等检索词对PubMed、Embase和CENTRAL数据库进行筛选。选择体重增加作为器官存活的指标来比较结果。提取的变量包括灌注的器官、灌注前的热缺血和冷缺血时间、灌注持续时间、灌注液流量、压力、温度、灌注液成分(细胞或无细胞氧载体、胶体和其他添加剂的存在情况)以及体重变化百分比。使用SPSS统计软件进行数据分析。
总共纳入44篇文章。与不含氧载体的无细胞灌注液相比,基于红细胞的灌注液导致的体重增加显著更低(11.3%对27.0%,p<0.001)。与无细胞灌注液相比,基于血红蛋白的氧载体导致的体重增加显著更低(16.5%对27%,p=0.006)。常温灌注导致的体重增加最少(14.6%),与低温(24.3%)和亚常温(25.0%)条件下显著不同(p<0.001),低温组和亚常温组之间无显著差异(24.3%对25.0%,p=0.952)。流速与体重增加之间存在正相关(β=13.1,R=0.390,p<0.001)。
氧载体、低流速和常温灌注液温度似乎可改善EVMP的结果。这些发现为改善器官移植结果提供了机会。